Neurologic care ... anytime?
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published October 12, 2016.
Article Versions
- Previous version (October 12, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Jamie L. Adams, MD,
- Benjamin P. George, MD, MPH and
- E. Ray Dorsey, MD, MBA
- Jamie L. Adams, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
VisualDx
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Benjamin P. George, MD, MPH and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- E. Ray Dorsey, MD, MBA
Shire Pharmaceuticals, Huntington's Disease Society of America, NINDS
NONE
received travel funding and/or honoraria from the American Academy of Neurology
Editorial board member for the Journal of Huntington's Disease; Editor of HD Insights
Patent application related to telemedicine
NONE
NONE
23andMe, Amgen, Avid Radiopharmaceuticals, Clintrex, Grand Rounds, Lundbeck, MC10, Shire, MedAvante, Transparency Life Sciences, National Institute of Neurological Disorders and Stroke, GlaxoSmithKline, Teva, UCB
NONE
NONE
Clinical practice, including telemedicine, as a movement disorder neurologist (20%)
AMC Health, Avid Radiopharmaceuticals, Biogen, Great Lakes Neurotechnologies, Lundbeck, Medtronic, Prana Biotechnology, Raptor Pharmaceuticals, Roche
Agency for Health Care Research and Quality, National Institute of Neurological Disorders and Stroke, National Science Foundation, Patient-Centered Outcomes Research Institute
University of California Irvine, Duke University
Davis Phinney Foundation, Michael J. Fox Foundation, Sage Bionetworks, Safra Foundations, Greater Rochester Health Foundation, Huntington Study Group
NONE
NONE
NONE
NONE
Grand Rounds (stock options)
has received compensation for expert testimony
- Department of Neurology (JLA, BPG, ERD) and Center for Human Experimental Therapeutics (JLA, ERD), University of Rochester Medical Center, NY.
- Correspondence to:
jamie_adams{at}urmc.rochester.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.